Fig. 8From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drugCumulative percentage drug diffused. a Ex vivo diffusion studies. b Ex vivo permeation studies. Values were expressed mean ± SD, n = 3Back to article page